Hematology, Transfusion and Cell Therapy
Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia
Adriana Seber; Claudio Galvão de Castro Junior; Lucila N. Kerbauy; Alexandre V. Hirayama; Carmem Bonfim; Juliana Folloni Fernandes; Mair Souza; Rony Schafell; Samir Nabhan; Sandra Regina Loggetto; Belinda Pinto Simões; Vanderson Rocha; Marcos de Lima; Renato L. Guerino-Cunha; Henrique Bittencourt;
Hematol Transfus Cell Ther. 2021;43 Supl 2:S13-21
BLINATUMOMAB BRIDGING THERAPY FOR EFFECTIVE MANAGEMENT OF MRD IN PRO-B ALL WITH CNS INVOLVEMENT: A CASE REPORT OF POST TRANSPLANT PATIENT AT 23 MONTHS AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION
Ceren Dehri Bahşi; Birol Güvenç;
Hematol Transfus Cell Ther. 2024;46 Supl 7:S72-3
Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina
María Manuela Clavijo; Juan Ignacio Ruiz; Luciana Ferrari; Alberto Gimenez Conca; Agostina Delorenzi; Leticia Rapan; Nicolas Cazap; María Marta Rivas; Eliana Moya; Lucía Agamennoni; Celina Guadalupe Vega; Julian Freue; Maria Eugenia Funes; Hernan Daniel Dick; Mercedes Mac Mullen; Alicia Navickas; Isolda Fernandez; Natalia Carnelutto; Claudia Vicente; María Moirano; Ana Lisa Basquiera; Carolina Belli;
10.1016/j.htct.2026.106530